openPR Logo
Press release

Transarterial Chemoembolization (TACE) Market to Reach USD 2.46 Billion by 2034

11-11-2025 11:21 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Transarterial Chemoembolization

Transarterial Chemoembolization

The Global Transarterial Chemoembolization (TACE) Market is experiencing substantial growth due to increasing prevalence of liver cancer, expanding adoption of minimally invasive oncology procedures, and technological innovations in image-guided therapy. According to Exactitude Consultancy, the market, valued at USD 1.56 billion in 2024, is projected to reach USD 2.46 billion by 2034, registering a CAGR of 4.7 % between 2025 and 2034.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49870

Growing clinical preference for locoregional treatments and ongoing development of drug-eluting microspheres with controlled drug release are transforming patient outcomes in hepatocellular carcinoma (HCC) and metastatic liver disease management.

Key Takeaways
• Market Size: USD 1.56 billion (2024) → USD 2.46 billion (2034)
• CAGR: 4.7 % (2025-2034)
• Dominant Application: Hepatocellular carcinoma (HCC) treatment accounts for over 60 % of market share
• Emerging Trend: AI-assisted catheter navigation and next-gen embolic materials
• Regional Leaders: North America dominates; Asia-Pacific is the fastest-growing region

Market Story
Transarterial Chemoembolization (TACE) is a minimally invasive, image-guided procedure combining localized chemotherapy delivery with arterial embolization to block tumor blood supply. It has become the standard of care for patients with intermediate-stage liver cancer who are not suitable for surgical resection.

The adoption of drug-eluting bead TACE (DEB-TACE) has revolutionized treatment outcomes by improving local drug concentration while minimizing systemic toxicity.
Technological advancements in angiographic systems, microcatheters, and real-time imaging platforms are enhancing procedural precision and patient recovery rates.

Additionally, the growing integration of AI-based navigation, 3D imaging, and robotic catheterization is enabling oncologists to perform safer, faster, and more targeted interventions.
Rising investments in oncology R&D, hospital infrastructure modernization, and multidisciplinary cancer care centers are further strengthening market growth.

Segmentation Overview
By Type
• Conventional TACE (cTACE)
• Drug-Eluting Bead TACE (DEB-TACE)

By Application
• Hepatocellular Carcinoma (HCC)
• Metastatic Liver Cancer
• Others (Neuroendocrine Tumors, Cholangiocarcinoma)

By End User
• Hospitals
• Specialty Cancer Centers
• Ambulatory Surgical Centers

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Explore Full Report here: https://exactitudeconsultancy.com/reports/49870/transarterial-chemoembolization-market

Recent Developments
• Boston Scientific Corporation expanded its EmbozeneTM microspheres portfolio with enhanced precision delivery systems.
• Sirtex Medical launched clinical trials for DEB-TACE combined with immunotherapy, targeting advanced-stage HCC.
• Terumo Corporation introduced LC Bead LumiTM microspheres with real-time visibility under imaging guidance.
• Merit Medical Systems invested in R&D for next-generation embolic beads compatible with image-guided robotic systems.
• Cook Medical expanded distribution of HepasphereTM microspheres across emerging Asian markets to support liver cancer treatment.

Expert Quote
"Transarterial Chemoembolization continues to redefine interventional oncology by merging precision delivery with advanced imaging.
As minimally invasive techniques and AI-assisted guidance mature, TACE will remain central to liver cancer therapy worldwide,"
said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49870

Market Drivers
• Rising global incidence of hepatocellular carcinoma (HCC)
• Growing preference for minimally invasive interventional oncology procedures
• Technological progress in drug-eluting microspheres and imaging systems
• Increasing R&D collaborations between device manufacturers and oncology centers
• Expanding healthcare access and cancer screening programs in emerging economies

Forecast and Outlook
Between 2025 and 2034, the TACE market will witness the convergence of locoregional oncology and digital imaging technologies.
The emergence of AI-guided catheterization, 3D vascular reconstruction, and combination therapy approaches will further improve survival rates and procedural accuracy.

Pharmaceutical and device companies are expected to collaborate on chemoembolization-drug combination trials, optimizing dose control and tumor targeting.
Asia-Pacific, in particular, is expected to become a key growth hub due to high HCC prevalence and improving interventional oncology infrastructure.

Regional Insights
• North America: Largest market; driven by advanced hospital systems and high HCC prevalence.
• Europe: Strong demand for DEB-TACE systems supported by structured reimbursement and clinical research funding.
• Asia-Pacific: Fastest-growing region; high liver cancer incidence and government initiatives for oncology treatment access.
• Latin America: Expanding adoption due to regional cancer awareness and tertiary care expansion.
• Middle East & Africa: Growing focus on non-surgical oncology therapies and hospital modernization.

Conclusion
The Global Transarterial Chemoembolization (TACE) Market stands at the intersection of interventional radiology and oncology innovation.
As new drug-eluting microspheres, robotic guidance systems, and AI imaging tools emerge, TACE will continue to evolve as a key therapeutic pillar in liver cancer management.
Manufacturers and healthcare providers investing in precision medicine and minimally invasive oncology ecosystems will lead the market's next phase of growth.

This report is also available in the following languages : Japanese (経動脈化学塞栓術市場), Korean (경동맥 화학색전술 시장), Chinese (经动脉化疗栓塞术市场), French (Marché de la chimioembolisation transartérielle), German (Markt für transarterielle Chemoembolisation), and Italian (Mercato della chemioembolizzazione transarteriosa), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/49870

Related Reports
Embolotherapy Market
https://exactitudeconsultancy.com/reports/30656/embolotherapy-market

U.S. Transarterial Chemoembolization Market
https://exactitudeconsultancy.com/reports/50563/u-s-transarterial-chemoembolization-market

Pulmonary Surfactant Market
https://exactitudeconsultancy.com/reports/76083/pulmonary-surfactant-market

Alzheimer's Disease Treatment Market
https://exactitudeconsultancy.com/reports/76109/alzheimer-s-disease-treatment-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transarterial Chemoembolization (TACE) Market to Reach USD 2.46 Billion by 2034 here

News-ID: 4263977 • Views:

More Releases from Exactitude Consultancy

Glycine Supplement Market to Reach USD 1.72 Billion by 2034
Glycine Supplement Market to Reach USD 1.72 Billion by 2034
The Global Glycine Supplement Market is experiencing robust growth as consumers increasingly prioritize nutritional balance, muscle recovery, and mental well-being. According to Exactitude Consultancy, the market, valued at USD 1.02 billion in 2024, is projected to reach USD 1.72 billion by 2034, growing at a CAGR of 5.3 % during 2025-2034. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49868 Glycine - a non-essential amino acid - is gaining attention for
Thyroid Test Market to Reach USD 3.94 Billion by 2034
Thyroid Test Market to Reach USD 3.94 Billion by 2034
The Global Thyroid Test Market is witnessing strong momentum as healthcare providers prioritize early detection of thyroid dysfunction through advanced diagnostics and automated testing solutions. According to Exactitude Consultancy, the market, valued at USD 2.45 billion in 2024, is projected to reach USD 3.94 billion by 2034, growing at a CAGR of 4.8 % during 2025-2034. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49866 Increased prevalence of hypothyroidism, hyperthyroidism, and
Food Allergy Diagnosis & Treatment Market to Surpass USD 11.2 Billion by 2034
Food Allergy Diagnosis & Treatment Market to Surpass USD 11.2 Billion by 2034
Pune, India, November 11, 2025 - The global Food Allergy Diagnosis & Treatment Market is projected to grow from USD 6.1 billion in 2024 to USD 11.2 billion by 2034, registering a CAGR of 6.2 %, according to Exactitude Consultancy. The surge in food allergy prevalence, particularly among children, coupled with advances in molecular diagnostics, immunotherapy, and AI-driven allergy profiling, is fueling robust market expansion worldwide. Download Full PDF Sample Copy
Systemic Lupus Erythematosus (SLE) Treatment Market to Reach USD 5.18 Billion by 2034
Systemic Lupus Erythematosus (SLE) Treatment Market to Reach USD 5.18 Billion by …
The Global Systemic Lupus Erythematosus (SLE) Treatment Market is undergoing rapid transformation as pharmaceutical innovation, biologic therapies, and improved diagnostic techniques redefine disease management. According to Exactitude Consultancy, the market, valued at USD 3.16 billion in 2024, is projected to reach USD 5.18 billion by 2034, growing at a CAGR of 5.1 % between 2025 and 2034. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49864 SLE - a chronic autoimmune

All 5 Releases


More Releases for TACE

Rising Alcohol Consumption Driving Market Growth Due To Increasing Health Risks: …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Is the Liver Cancer Market Size and Projected Growth Rate? In recent years, there has been significant growth in the liver cancer market. Forecasted to expand from $2.94 billion in 2024 to $3.37 billion in 2025, it is expected to witness a compound annual growth rate (CAGR) of 14.5%. This historical growth can
Rising Alcohol Consumption Driving Market Growth Due To Increasing Health Risks: …
The Liver Cancer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Liver Cancer Market Size and Projected Growth Rate? The size of the liver cancer market has seen a swift expansion in recent times. The market is projected to rise from $2.94 billion
Transarterial Chemoembolization (TACE) Market : An Overview Report
Introduction: Transarterial Chemoembolization (TACE) is a minimally invasive procedure used to treat liver cancer. It combines chemotherapy and embolization to target tumors directly. During the procedure, chemotherapy drugs are injected into the blood vessels supplying the tumor, followed by the use of embolic agents to block blood flow, trapping the chemotherapy in the tumor. This treatment is primarily used for patients with hepatocellular carcinoma (HCC) and metastatic liver cancer. TACE has
Transarterial Chemoembolization (TACE) Market Size, Share, Trends, Opportunities …
Global transarterial chemoembolization (TACE) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 3,404.56 million by 2028 growing at a CAGR of 8.25% in the above-mentioned forecast period. Transarterial Chemoembolization (TACE) Market Scope and Market Size Transarterial chemoembolization (TACE) market is segmented on the basis of procedure type, product type, indication and end-user. The growth
08-04-2023 | Health & Medicine
DBMR
Transarterial Chemoembolization (TACE) Market account to USD 3,404.56 million by …
The credible Transarterial Chemoembolization (TACE) market report covers a thorough study of current situation of the global market along with several market dynamics. The major areas of market analysis such as market definition, market segmentation, competitive analysis and research methodology are studied very carefully and precisely in the whole report. And not to mention, the report is amazingly characterized by using several charts, graphs and tables depending on the extent
New Era of Plasma Thawing Systems Market 2020-2025: Technological Advancement an …
Overview of Global Plasma Thawing Systems Market: This report provides in-depth study of "Global Plasma Thawing Systems Market 2020" using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Plasma Thawing Systems Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Plasma Thawing Systems reduces thaw times and has features for controlling temperature and agitation, plasma thawer